Latest European Market News

Little Green Pharma reports record quarterly revenue and announces a transformative merger with Cannatrek, creating a leading vertically integrated medicinal cannabis group with strong European growth prospects.

Bioxyne Limited has reported a record $17.2 million in quarterly revenue, driven by strong growth in its cannabis and psychedelics segments, alongside strategic international expansions including a Frankfurt dual listing and new manufacturing agreements.

Altech Batteries has won conditional approval for a €46.11 million German government grant to support its innovative CERENERGY Sodium-Chloride Solid-State battery project, advancing plans for a 120 MWh manufacturing facility in Saxony.

Memphasys has secured CE Mark approval for its Felix™ sperm selection system, enabling full commercial rollout across Europe and activating multi-year contracts worth over A$1.3 million. This milestone signals the company’s transition into a revenue-scaling phase with global growth ambitions.

CPP Investments and Goodman Group have launched a A$14 billion partnership to develop data centres across key European markets, marking CPP’s first foray into European digital infrastructure.

Memphasys has inked a five-year supply agreement with Italy’s Centro Fertilita Assistita, marking its first major European contract and setting the stage for broader adoption of its Felix™ sperm isolation system.

ECS Botanics is strategically preparing for entry into the US medicinal cannabis market, leveraging its EU-GMP certification and proprietary genetics amid evolving regulatory landscapes.

Yugo Metals Limited has secured a dual listing on Germany’s Frankfurt and Dusseldorf Stock Exchanges, enhancing its access to European investors, while initial drilling at its Sinjakovo Project in Bosnia-Herzegovina reveals encouraging silver-lead-zinc mineralisation.

Temas Resources has engaged a European consultant to elevate its investor awareness across key markets, aiming to strengthen its presence in Germany and broader Europe.

Prospech Limited has significantly increased its Jokikangas project tenure in northern Finland, targeting critical minerals like yttrium and niobium amid soaring European prices. The expansion positions the company strongly within a Tier-1 mining jurisdiction as it plans initial exploration activities.

Memphasys Limited has restructured its leadership by eliminating the CEO role to back a direct-selling global commercialisation strategy for its Felix™ System, anticipating imminent CE Mark approval to enter the European IVF market.

International Graphite Limited projects robust financial returns from its new expandable graphite facility joint venture in Germany, targeting production start in mid-2027 with rapid payback and low capital costs.